Rod Raynovich's  Instablog

Rod Raynovich
Send Message
Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 30 years executive experience including Abbott and JNJ and has been involved three successful start-ups. He has a B.S, from Penn State University and an MBA from... More
My company:
Raygent Capital
My blog:
raygent.com
  • Rayno Life Science Portfolio: Huge Year For Diagnostics And Tools Stocks 0 comments
    Jul 13, 2012 3:04 PM | about stocks: ABAX, EXAS, ILMN, NEOG

    2012: Four Big Winners Up 30-40% in DX and Tools Portfolio: ABAX, EXAS, GPRO, ILMN

    In a volatile year with dire macro news and low growth forecasts the NASDAQ was up 10 % YTD and the Rayno Life Science Portfolio had its best year since 2010. M&A continues to play a big role and over the past two years five of our portfolio companies have been acquired including GenProbe (NASDAQ:GPRO) by Hologic (NASDAQ:HOLX) this year but M&A is down 30% in H1 2012 according to GenomeWeb. A new M&A trend is the acquisition of Diagnostic companies by large more diversified Tools companies such as Agilent's (NYSE:A) purchase of Dako for $2.2B, as they strive to add clinical content to their product mix.

    Another underlying trend is personalized medicine and companion diagnostics and we are looking for smaller companies that are in the forefront of this trend. Currently in our portfolio Illumina (NASDAQ:ILMN), Qiagen (NASDAQ:QGEN) and Response Genetics (NASDAQ:RGDX) have strategies within the Personalized Medicine theme.

    We are left with only eleven companies in our portfolio so we need to look at new picks to reload. With the AACC Clinical Chemistry Conference next week we will be on the hunt for new ideas.

    2012   Original Price Price % Price Price    
        Recomm   Dec'10 Ret 7/1/11 7/13/12 %YTD  
                       
    Abaxis ABAX 2/2/09 15 26.85 79 27.77 39.5 42.6  
    CardioV.Sys. CSII 11/5/10 7.15 11.66 63 15.45 10.55 5.4  
    Celera CRA 3/28/10 7 6.3 18 acquired    
    Exact Sci EXAS 12/10/10 5.6 5.98 6.8 8.48 11.45 40.5  
    GenProbe GPRO 2/2/09 45 58.35 29.7 69.79 82.55 39.6 acquired
    Illumina ILMN 2/2/09 29 63.34 118 76 40.4 32.5  
    Immucor BLUD 4/5/10 20 19.83 0 20.73 acquired  
    Alere ALR 2/2/09 25 36.6 46 37.35 18.65 -19.2  
    MicroFluidics MFLU 7/6/10 0.77 1.34 74 acquired    
    NeoGen NEOG 7/2/10 26 41.03 58 45.33 44.6 45  
    Qiagen QGEN 3/15/10 21.5 19.55 -9 19.07 16.9 22.8  
    Quidel QDEL 6/16/10 12.4 14.45 16 15.3 16.75 11  
    Sequenom SQNM 11/18/09 3.75 8.03 114 7.44 3.88 -12.4  
    SeraCare SRLS 11/18/09 2.75 4.75 73 3.77 acquired  
    ResponseG RGDX 2/3/12 1.50     new 1.30 (13)  

    Disclosure: I am long ALR, CSII, ILMN, RGDX.

    Stocks: ABAX, EXAS, ILMN, NEOG
Back To Rod Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.